Compugen (CGEN) Other Non-Current Assets (2009 - 2026)
Compugen (CGEN) posted quarterly Other Non-Current Assets of $1.3 million for Q1 2026, down 20.84% year-over-year from $1.6 million in Q1 2025, and little changed on a QoQ basis from $1.3 million in Q4 2025.
Compugen (CGEN) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Compugen has reported Other Non-Current Assets for 18 years, with the latest figure at $1.3 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $1.3 million, down 20.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 20.84% YoY), and the FY2025 annual result was $1.3 million, down 31.51% from the prior year.
- Other Non-Current Assets held at $1.3 million in Q1 2026, from $1.3 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.9 million in Q1 2022 and troughed at $922000.0 in Q2 2024.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Other Non-Current Assets.
- The widest annual swing landed in 2024, when Other Non-Current Assets tumbled 51.78%; it then surged 88.5% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $1.9 million in 2022, then plunged by 35.07% to $1.2 million in 2023, then jumped by 53.12% to $1.9 million in 2024, then plunged by 31.51% to $1.3 million in 2025, then advanced by 0.15% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $1.3 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 1.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 1.73 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.64 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 922,000.00 |
| Mar 31, 2024 | 934,000.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 1.91 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.90 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 1.91 Mn |
| Mar 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 3.13 Mn |
| Sep 30, 2021 | 1.91 Mn |
| Jun 30, 2021 | 1.91 Mn |